| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/18/2004 | CN1476334A Use of bromelain for treatment of inflammatory diseases and for adjuvant therapy during wound healing processes |
| 02/18/2004 | CN1476331A Method and preparations having effect agaist allergic symptoms |
| 02/18/2004 | CN1475213A Soyisoflavone soft capsule and its preparation technology |
| 02/18/2004 | CN1475137A Chicken feed additive |
| 02/18/2004 | CN1475136A 鱼饲料添加剂 Fish feed additive |
| 02/18/2004 | CN1138859C Infection clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 02/18/2004 | CN1138774C Substituted 6,6-hetero-bicyclic derivatives |
| 02/18/2004 | CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 02/18/2004 | CN1138564C Influenza vaccine |
| 02/18/2004 | CN1138562C Use of muteins of wild-type cytokines as immunogens |
| 02/18/2004 | CN1138548C Crustaceous extract health care foods and preparation method thereof |
| 02/18/2004 | CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 02/18/2004 | CN1138545C Use of penciclovir for treatment of human herpes-virus-8 |
| 02/18/2004 | CN1138472C Dipeptide apoptosis inhibitors and use thereof |
| 02/17/2004 | US6693132 Methods for using alkanoyloxymethyl esters |
| 02/17/2004 | US6693118 E.G., 1-(2-(6,7-METHYLENEDIOXYNAPHTH-2-YL)-ETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6-TETRAHYDROPYRIDINE AND 1-2-(4-CYCLOHEXENYLPHENYL)-ETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6 -TETRAHYDROPYRIDINE; apoptosis inhibition; treatment of graft rejection or of acute or chronic rheumatoid arthritis |
| 02/17/2004 | US6693116 Adenosine receptor ligands |
| 02/17/2004 | US6693113 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections |
| 02/17/2004 | US6693108 Pyrimidinyl-guanidine derivatives |
| 02/17/2004 | US6693102 Pyridine-substituted pyrazolopyridine derivatives |
| 02/17/2004 | US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 02/17/2004 | US6693096 Treatment of inflammation-associated disorders using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors |
| 02/17/2004 | US6693086 Eliciting nonantigen and strong antigen specific immune response; cancer, allergic inflammation and/or infectious disease prevention |
| 02/17/2004 | US6692958 Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations |
| 02/17/2004 | US6692956 Recombinant adenoviral vectors |
| 02/17/2004 | US6692753 Potentiation of the immune response |
| 02/17/2004 | US6692750 Introducing into cells recombinant alphavirus rna genome and helper rna encoding alphavirus structural proteins, including coding sequences for proteins and cis acting replication signals; incubating to produce infectious virus particles |
| 02/17/2004 | US6692747 Peptide for use in the treatment of infections, viral and cancer diseases |
| 02/17/2004 | US6692735 Truncated variant of c6 beta-chemokine leukotactin-1 polypeptide consisting of specified amino acid sequence |
| 02/17/2004 | CA2252401C Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors |
| 02/17/2004 | CA2051501C 1-phenyl-3-phenyl-2-propyne-1-ones as calcium uptake inhibitors |
| 02/12/2004 | WO2004013629A2 Screening for agents suitable for treatment of leukocyte associated inflammatory diseases |
| 02/12/2004 | WO2004013146A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 02/12/2004 | WO2004013145A1 Pyrrolotriazine kinase inhibitors |
| 02/12/2004 | WO2004013144A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/12/2004 | WO2004013140A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 02/12/2004 | WO2004013132A1 Furanthiazole derivatives as heparanase inhibitors |
| 02/12/2004 | WO2004013130A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | WO2004013109A1 Resorcinol derivative |
| 02/12/2004 | WO2004013102A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines |
| 02/12/2004 | WO2004013093A2 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/12/2004 | WO2004013085A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/12/2004 | WO2004012817A2 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs |
| 02/12/2004 | WO2004012771A1 Pharmaceutical compositions comprising cyclosporin for oral administration |
| 02/12/2004 | WO2004012770A1 Oral pharmaceutical compositions comprising cyclosporin |
| 02/12/2004 | WO2004012768A1 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and/or a mtor inhibitor |
| 02/12/2004 | WO2004012766A1 Method for correcting immune responses and medicinal agent |
| 02/12/2004 | WO2004012763A1 Modulation of mesenchymal cells via iga-receptors |
| 02/12/2004 | WO2004012751A1 Bacterial cell wall skeleton component preparaion |
| 02/12/2004 | WO2004012746A2 New uses for inhibitors of inosine monophosphate dehydrogenase |
| 02/12/2004 | WO2004012738A1 Novel salt and polymorphs of desloratadine hemifumarate |
| 02/12/2004 | WO2004012716A1 Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant |
| 02/12/2004 | WO2004012653A2 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 02/12/2004 | WO2004012651A2 Composition for heart disease, method to prepare same and uses thereof |
| 02/12/2004 | WO2003103604A3 Gamma lactams as prostaglandin agonists and use thereof |
| 02/12/2004 | WO2003094963A3 Methylated immunostimulatory oligonucleotides and methods of using the same |
| 02/12/2004 | WO2003094957A3 Methods of therapy for inducing tolerance |
| 02/12/2004 | WO2003091414A3 Adipocyte complement related protein zacrp8 |
| 02/12/2004 | WO2003091259A8 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 02/12/2004 | WO2003077882A3 Preparation of sterile stabilized nanodispersions |
| 02/12/2004 | WO2003072789A3 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 02/12/2004 | WO2003070968A3 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/12/2004 | WO2003070236A3 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2003062467A3 Tissue rejection |
| 02/12/2004 | WO2003060142A3 Compositions and methods for controlled release |
| 02/12/2004 | WO2003060080A3 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 02/12/2004 | WO2003059264A3 Methods for the induction of professional and cytokine-producing regulatory cells |
| 02/12/2004 | WO2003057141A3 Methods for improving the aesthetic appearance of skin |
| 02/12/2004 | WO2003049723A3 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
| 02/12/2004 | WO2003039485A3 Stable liquid pharmaceutical formulation of igg antibodies |
| 02/12/2004 | WO2003037916A3 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/12/2004 | WO2003033653B1 Affinity enhancement agents |
| 02/12/2004 | WO2003033526A3 Synthesis of cyclosporin analogs |
| 02/12/2004 | WO2003013424A3 Use of r-nsaid compounds for anti-hiv treatment |
| 02/12/2004 | WO2003008365A3 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2002100330A3 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES |
| 02/12/2004 | WO2002090542A8 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 02/12/2004 | WO2002076507A3 Uses of opg ligand to modulate immune responses |
| 02/12/2004 | WO2002074346A3 Targeting chemical compounds to cells |
| 02/12/2004 | WO2002066647A3 Type 2 ctokine receptor and nucleic acids encoding same |
| 02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
| 02/12/2004 | WO2002053700A3 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 02/12/2004 | US20040030141 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them |
| 02/12/2004 | US20040030138 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 02/12/2004 | US20040030115 Nucleic acids containing the coding regions of the genes encoding such proteins, vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins; useful for diagnosing and treating disorders related to them |
| 02/12/2004 | US20040030106 Novel compounds and process |
| 02/12/2004 | US20040030096 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 02/12/2004 | US20040029965 Formulations for reducing or eliminating toxicity of enviromental hormones containing ursodeoxycholic acid |
| 02/12/2004 | US20040029950 Nervous system and psychological disorders |
| 02/12/2004 | US20040029943 Antiallergens; antiinflammatory agents; hypotensive agents; central nervous system disorders |
| 02/12/2004 | US20040029939 Inhibitors of IMPDH enzyme |
| 02/12/2004 | US20040029938 Medicaments |
| 02/12/2004 | US20040029937 Benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 02/12/2004 | US20040029932 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/12/2004 | US20040029928 Tumor necrosis factor alpha-converting enzyme inhibitor; rheumatic diseases; antiarthritic agents; infections; autoimmune diseases; antidiabetic agents |
| 02/12/2004 | US20040029925 Central nervous system disorders; psychological disorders; gastrointestinal disorders |
| 02/12/2004 | US20040029916 Antiarthritic agents; skin disorders; Crohn's disease |
| 02/12/2004 | US20040029908 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 02/12/2004 | US20040029902 2,4-Pyrimidinediamine compounds and their uses |